EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets

Han Zhang, Jiulu Zhao, Jizhang Yu, Xi Zhang, Shuan Ran, Song Wang, Weicong Ye, Zilong Luo, Xiaohan Li, Yanglin Hao, Junjie Zong, Ran Li und 7 weitere

Frontiers in Cardiovascular Medicine · 27.11.2024 · 11

DOI: 10.3389/fcvm.2024.1489438 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 27.11.2024. Verfasst von Han Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) is responsible for approximately 30% of annual global mortality rates, yet existing treatments for this condition are considered less than ideal. Despite being previously overlooked, lactate, a byproduct of glycolysis, is now acknowledged for its crucial role in the cellular functions of the cardiovascular system. Recent studies have shown that lactate influences the proliferation, differentiation, and activation of immune cells through its modulation of post-translational protein modifications, thereby affecting the development and prognosis of cardiovascular disease. Consequently, there has been a notable increase in interest towards drug targets targeting lactylation in immune cells, prompting further exploration. In light of the swift advancements in this domain, this review article is dedicated to examining lactylation in cardiovascular disease and potential drug targets for regulating lactylation, with the aim of enhancing comprehension of this intricate field.

Schlagwörter

Stichwörter der Autor:innen

cardiovascular diseaseglycolysisimmune celllactate metabolismlactylation

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Center for Translational Medicine, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, Hubei, China.

Zitieren

APA

Zhang, H., Zhao, J., Yu, J., Zhang, X., Ran, S., Wang, S., Ye, W., Luo, Z., Li, X., Hao, Y., Zong, J., Li, R., Lai, L., Zheng, K., Huang, P., Zhou, C., Wu, J., Li, Y., & Xia, J. (2024). Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1489438

Vancouver

Zhang H, Zhao J, Yu J, Zhang X, Ran S, Wang S, et al. Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1489438

BibTeX
@article{Zhang2024,
  author = {Zhang, Han and Zhao, Jiulu and Yu, Jizhang and Zhang, Xi and Ran, Shuan and Wang, Song and Ye, Weicong and Luo, Zilong and Li, Xiaohan and Hao, Yanglin and Zong, Junjie and Li, Ran and Lai, Longyong and Zheng, Kexiao and Huang, Pinyan and Zhou, Cheng and Wu, Jie and Li, Yuan and Xia, Jiahong},
  title = {Lactate metabolism and lactylation in cardiovascular disease: novel mechanisms and therapeutic targets},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fcvm.2024.1489438}
}
Kostenlos starten →